Showing 37,921 - 37,940 results of 99,993 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (we decrease)) ))', query time: 1.75s Refine Results
  1. 37921

    Bar graphs showing the proportions (a) and absolute volumes (b) of the CAM components. by Andrew Ndegwa Makanya (2591125)

    Published 2016
    “…<p><b>a:</b> The mesoderm remained the largest component during the entire growth period at about 70%, declining slightly at E18. …”
  2. 37922

    miR-29a modulates neuronal differentiation of MSCs by targeting REST. by Ping Duan (312653)

    Published 2014
    “…<p>(A) Lentiviral infection of miR-29a inhibitor decreases miR-29a expression in MSCs. …”
  3. 37923

    Effects of isobavachalcone treatment on BV-2 cells and Neuro-2a cells. by Haoran Jing (3621779)

    Published 2017
    “…C: Isobavachalcone decreased microglial-induced neuro-2a death in a co-culture system. …”
  4. 37924

    Description of the role of the pharmacist in a multiprofessional team focused on the care of hospitalized elderly by Isabela Vaz Leite Pinto (12817700)

    Published 2022
    “…A total of 163 pharmaceutical interventions were carried out, representing a mean of 6.79 interventions/patient and 82.2% acceptance. …”
  5. 37925

    Epidemiology of Orbital and Preseptal Cellulitis in the United States: A 13-Year Analysis by Shazia Dharssi (20563728)

    Published 2025
    “…Young adults (ages 21–44) comprise a majority of patients with either preseptal or orbital cellulitis (31.7%; 95% CI, 30.5–33.0%). …”
  6. 37926
  7. 37927

    A Unique Combination of Male Germ Cell miRNAs Coordinates Gonocyte Differentiation by Skye C. McIver (170151)

    Published 2012
    “…We identified seven differentially expressed miRNAs between gonocytes and spermatogonia (down-regulated: miR-293, 291a-5p, 290-5p and 294*, up-regulated: miR-136, 743a and 463*). …”
  8. 37928

    DataSheet_1_Reduced prevalence of drug-related problems in psychiatric inpatients after implementation of a pharmacist-supported computerized physician order entry system - a retro... by Katharina Wien (18330384)

    Published 2024
    “…To date, no study has been reported on the types and prevalence of drug-related problems (DRPs) before and after CPOE implementation in a psychiatric inpatient setting. The aim of this retrospective before-and-after cohort study was to investigate whether the implementation of a CPOE system with CDSS accompanied by the introduction of regular medication plausibility checks by a pharmacist led to a decrease of DRPs during hospitalization and unsolved DRPs at discharge in psychiatric inpatients.…”
  9. 37929
  10. 37930

    Data Sheet 1_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
  11. 37931

    Data Sheet 2_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
  12. 37932

    Data Sheet 3_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
  13. 37933

    Data Sheet 4_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
  14. 37934

    Temporal changes in the clinical-epidemiological profile of patients with Chagas disease at a referral center in Brazil by Alejandro Marcel Hasslocher-Moreno (3460265)

    Published 2022
    “…Regarding the patients who were followed up at the referral center, there was a progressive increase in the mean age and a concomitant decrease in the number of new patients. …”
  15. 37935

    Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma by Zheng Liang (140689)

    Published 2014
    “…Moreover, a decrease in pCcd2 and an increase in CyclinB1 levels were observed which is consistent with the G2/M cell cycle arrest. …”
  16. 37936

    DataSheet_1_Factors governing seawater carbonate dynamics in a macroalgal habitat.pdf by Ja-Myung Kim (1531744)

    Published 2022
    “…<p>Photosynthetic organisms shift the dynamics of surface pCO<sub>2</sub> driven by the sea surface temperature change (thermodynamic driver) by assimilating inorganic C from seawater. Here we measured net C uptake in a macroalgal habitat of coastal Korea for two years (2019-2020) and found that the macroalgal habitat contributed 5.8 g C m<sup>−2</sup> month<sup>−1</sup> of the net C uptake during the growing period (the cooling period, September−May). …”
  17. 37937

    Supplementary Material for: Alcohol use and types and ischemic stroke: a systematic review and meta-analysis by figshare admin karger (2628495)

    Published 2025
    “…Data analysis was performed using Meta XL, version 5.3. Results: The total number of included participants was 21,293,471 from 125 studies. …”
  18. 37938

    The representative trace of the LDF signal after the intravital injection of ADP to a mouse (a), parameters of the curve calculated by PAMA software, the LDU values are multiplied... by Tomasz Przygodzki (4277908)

    Published 2016
    “…<p>The following parameters characterizing the curve were calculated using PAMA software, as described in ‘<i>Materials and Methods</i>’ and are expressed in arbitrary Laser Doppler Flow units (LDU): <b>A</b><sub><b>max</b></sub><b>—</b>the maximum decrease in blood flow with respect to the baseline; <b>DA–</b>the maximal restoration of flow with respect to the baseline; <b>T</b><sub><b>d</b></sub><b>—</b>time from the injection of ADP to 10% of the maximum decrease in blood flow (A<sub>max</sub>); <b>T</b><sub><b>r</b></sub><b>−</b>time from 10% to 90% of the maximum decrease in blood flow (A<sub>max</sub>); <b>T</b><sub><b>c</b></sub><b>−</b>time from 90% of A<sub>max</sub> to 90% of DA; <b>T</b><sub><b>f</b></sub><b>−</b>time from 90% of DA to 10% of DA; <b>V</b><sub><b>0r</b></sub><b>–</b>the maximal rate of the decrease in blood flow; <b>V</b><sub><b>Avgr</b></sub><b>−</b>the rate of decrease averaged through T<sub>r</sub>; <b>V</b><sub><b>0f</b></sub><b>–</b>the maximal rate of the restoration of blood flow; <b>V</b><sub><b>Avgf</b></sub><b>−</b>the rate of restoration averaged through T<sub>f</sub>; <b>AUC–</b>the area under the curve from 10% of A<sub>max</sub> to 10% DA; <b>AUC</b><sub><b>r</b></sub><b>−</b>the area under the curve from 10% to 90% of A<sub>max</sub>; <b>AUC</b><sub><b>c</b></sub><b>−</b>the area under the curve from 90% of A<sub>max</sub> to 90% of DA; <b>AUC</b><sub><b>f</b></sub><b>−</b>the area over the curve from 90% to 10% of DA.…”
  19. 37939
  20. 37940

    Protein-protein docking for Parkin and a charged E2∼Ub complex. by Thomas R. Caulfield (655752)

    Published 2014
    “…The docking in the same position is shown and rotated 180° to reveal the other side. Residues of the Ubch5a-Ub complex are indicated by color (dark green and brown, respectively). …”